BDBM520215 N-((1-Cyanopyrrolidin-3- yl)methyl)-1-(2,4-dichlorobenzyl)- 1H-indazole-3-carboxamide::US11130748, Example 28::US11130748, Example 29

SMILES O=C(NCC1CCN(C1)C#N)c1nn(Cc2ccccc2)c2ccccc12

InChI Key InChIKey=KINAZPSFJPPTNP-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 520215   

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mission Therapeutics

US Patent
LigandPNGBDBM520215(N-((1-Cyanopyrrolidin-3- yl)methyl)-1-(2,4-dichlor...)
Affinity DataIC50: 100nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2022
Entry Details
US Patent

TargetUbiquitin carboxyl-terminal hydrolase 30(Human)
Mission Therapeutics

US Patent
LigandPNGBDBM520215(N-((1-Cyanopyrrolidin-3- yl)methyl)-1-(2,4-dichlor...)
Affinity DataIC50: 5.50E+3nMAssay Description:Dilution plates were prepared at 21 times the final concentration (2100 μM for a final concentration of 100 μM) in 50% DMSO in a 96-well po...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/8/2022
Entry Details
US Patent